| scholarly article | Q13442814 |
| P50 | author | Ralph H. Hruban | Q21063634 |
| Christophe Rosty | Q51118591 | ||
| Michael Goggins | Q63021511 | ||
| Marcia Irene Canto | Q88872709 | ||
| Charles J Yeo | Q96191880 | ||
| Keith D Lillemoe | Q103302432 | ||
| Marianna L Zahurak | Q114398788 | ||
| P2093 | author name string | Daniel W Chan | |
| John L Cameron | |||
| Françoise Carnot | |||
| Laurence Christa | |||
| Scott Kuzdzal | |||
| William M Baldwin | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic ductal adenocarcinoma | Q18555956 |
| pancreas | Q9618 | ||
| adenocarcinoma | Q356033 | ||
| biomarker | Q864574 | ||
| invasive ductal carcinoma | Q1671685 | ||
| pancreatic ductal carcinoma | Q8263002 | ||
| P304 | page(s) | 1868-1875 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology | |
| P478 | volume | 62 |
| Q25257396 | A novel mass spectrometry-based assay for GSK-3beta activity |
| Q30826870 | A path or a new road in laboratory diagnostics? Biological mass spectrometry: facts and perspectives |
| Q24800551 | An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures From Mass Spectrometers |
| Q41832328 | An improved synthesis of 1'-[18F]fluoroethyl-β-D-lactose ([18F]-FEL) for positron emission tomography imaging of pancreatic cancer |
| Q33304961 | Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias |
| Q24810545 | Application of serum SELDI proteomic patterns in diagnosis of lung cancer |
| Q33319301 | Applications of SELDI-MS technology in oncology |
| Q33536646 | Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling |
| Q33722303 | Biochips that sequentially capture and focus antigens for immunoaffinity MALDI‐TOF MS: A new tool for biomarker verification |
| Q40442478 | Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death |
| Q30969575 | Clinical applications of proteomics: proteomic pattern diagnostics |
| Q33256357 | Contributions of advanced proteomics technologies to cancer diagnosis |
| Q34458903 | Current status of molecular markers for early detection of sporadic pancreatic cancer |
| Q30945833 | Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT |
| Q33299979 | Discovery and validation of serum biomarkers expressed over the first twelve weeks of Fasciola hepatica infection in sheep |
| Q33282542 | Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology |
| Q21144689 | Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis |
| Q27014027 | Early diagnosis of pancreatic cancer: challenges and new developments |
| Q33944966 | Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia |
| Q47177056 | Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis |
| Q51599172 | Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. |
| Q35094629 | Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas |
| Q35630292 | High-accuracy proteome maps of human body fluids |
| Q33262623 | Human body fluid proteome analysis |
| Q34130267 | Identification of Regional Lymph Node Involvement of Colorectal Cancer by Serum SELDI Proteomic Patterns |
| Q35867858 | Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer |
| Q46619318 | Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology |
| Q36328508 | Identifying molecular markers for the early detection of pancreatic neoplasia |
| Q37130537 | Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen. |
| Q35497551 | Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers |
| Q38041420 | Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents |
| Q37848311 | Mass spectrometry-based proteomics of endoscopically collected pancreatic fluid in chronic pancreatitis research |
| Q26766654 | Mechanisms of interleukin-22's beneficial effects in acute pancreatitis |
| Q36485336 | Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts |
| Q36625481 | Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas |
| Q37133363 | Novel approaches to smoothing and comparing SELDI TOF spectra |
| Q36558301 | Novel technologies for the discovery and quantitation of biomarkers of toxicity |
| Q38406264 | Optimization of precursor synthesis, formulation and stability of 1'-[18F]fluoroethyl-β-D-lactose ([18F]FEL) for preclinical studies in detection of pancreatic cancer |
| Q36308123 | Overexpression of annexin 1 in pancreatic cancer and its clinical significance |
| Q50203906 | PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. |
| Q34526464 | Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality |
| Q42704467 | Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine |
| Q35627301 | Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis |
| Q51110150 | Potential effects of calcium binding protein S100A12 on severity evaluation and curative effect of severe acute pancreatitis. |
| Q46003601 | Preclinical PET imaging of HIP/PAP using 1'-18F-fluoroethyl-β-D-lactose. |
| Q34315514 | Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts |
| Q60609764 | Proteomanalyse |
| Q38207538 | Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors |
| Q21260399 | Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients |
| Q33938187 | Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. |
| Q33369053 | Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study |
| Q35185708 | Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer |
| Q92542101 | Role of Regenerating Islet-Derived Protein 3A in Gastrointestinal Cancer |
| Q38977902 | SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer |
| Q33959412 | Screening for pancreatic cancer: why, how, and who? |
| Q33642806 | Searching for Potential Ovarian Cancer Biomarkers with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry |
| Q34275247 | Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. |
| Q42220988 | Short Gel, Long Gradient Liquid Chromatography Tandem Mass Spectrometry to Discover Urinary Biomarkers of Chronic Pancreatitis |
| Q37132800 | State of the art in tumor antigen and biomarker discovery. |
| Q38342863 | Synthesis and ex vivo autoradiographic evaluation of ethyl-β-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[18F]fluoro-β-D-glucopyranoside--a novel radioligand for lactose-binding protein: implications for early detection of pancreatic carcinomas with PET. |
| Q36685675 | Target discovery and validation in pancreatic cancer |
| Q34608851 | The current state of proteomics in GI oncology |
| Q33404355 | The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry |
| Q35450240 | The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas |
| Q33822314 | The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer |
| Q42114237 | Urinary Proteomics Yield Pathological Insights for Ureteropelvic Junction Obstruction |
| Q36857512 | iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance |
| Q33420435 | the need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis |
Search more.